Therapeutic angiogenesis gains a leg to stand on

Molecular Therapy

Volumn 16, Issue 5, 2008, Pages 808-810

  Rück, Andreas ^a   Sylvén, Christer ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 5; PLACEBO; PLASMID DNA; PLASMID VECTOR; VASCULOTROPIN 165;

ANGIOGENIC GENE THERAPY; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LEG ISCHEMIA; LEG ULCER; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; NOTE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; RISK REDUCTION; TREADMILL EXERCISE; TREATMENT DURATION; ULCER HEALING; VIRAL GENE DELIVERY SYSTEM;

EID: 42549133465     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.65     Document Type: Note

References (20)

1. S Yla-Herttuala K Alitalo Gene transfer as a tool to induce therapeutic vascular growth Nat Med 9 2003 694 701
2. D Orlic J Kajstura S Chimenti F Limana I Jakuniuk F Quaini Mobilized bone marrow cells repair the infarcted heart, improving function and survivaly Proc Natl Acad Sci USA 98 2001 10344 10349
3. CE Murry MH Soonpaa H Reinecke H Nakajima HO Nakajima M Rubart Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts Nature 428 2004 607 608
4. LB Balsam AJ Wagers JL Christensen T Kofidis IL Weissmann RC Robbins Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium Nature 428 2004 668 673
5. JM Nygren S Jovinge M Breitbach P Säwén W Röll J Hescheler Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation Nat Med 10 2004 494 501
6. S Nikol I Baumgartner E Van Belle C Diehm A Visoná MC Capogrossi Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia Mol Ther 16 2008 972 978
7. J Muhlhauser R Pili MJ Merrill H Maeda A Passaniti RG Crystal In vivo angiogenesis induced by recombinant adenovirus vectors coding either for secreted or nonsecreted forms of acidic fibroblast growth factor Hum Gene Ther 6 1995 1457 1465
8. J Jr Safi AF Jr DiPaula T Riccioni J Kajstura G Ambrosio LC Becker Adenovirus-mediated acidic fibroblast growth factor gene transfer induces angiogenesis in the nonischemic rabbit heart Microvasc Res 58 1999 238 249
9. H Tabata M Silver JM Isner Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo : critical role of secretion signal in use of naked DNA Cardiovasc Res 35 1997 470 479
10. F Soubrier B Cameron B Manse S Somarriba C Dubertret G Jaslin pCOR: a new design of plasmid vectors for nonviral gene therapy Gene Ther 6 1999 1482 1488
11. B Witzenbichler A Mahfoudi F Soubrier A Le Roux D Branellec HP Schultheiss Intramuscular gene transfer of fibroblast growth factor-1 using improved pCOR plasmid design stimulates collateral formation in a rabbit ischemic hindlimb model J Mol Med 84 2006 491 502
12. M Hedman J Hartikainen M Syvänne J Stjernvall A Hedman A Kivelä Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT) Circulation 107 2003 2677 2683
13. TD Henry CL Grines MW Watkins N Dib G Barbeau R Moreadith Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials J Am Coll Cardiol 50 2007 1038 1046
14. 165 gene therapy in patients with stable severe angina pectoris: a randomized double-blind placebo-controlled study—the Euroinject One Trial J Am Coll Cardiol 45 2005 982 988
15. M Gyöngyösi A Khorsand S Zamini W Sperker C Streblow J Kastrup NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding VEGF A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE Multicenter Double-Blind Randomized Study Circulation 112 suppl I 2005 I-157 I-165
16. US National Institutes of Health Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for Revascularization (AWARE)
17. L Norgren WR Hiatt JA Dormandy MR Nehler KA Harris FG Fowkes Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) Eur J Vasc Endovasc Surg 33 suppl 1 2007 S1 S75
18. YH Kusumanto V van Weel NH Mulder AJ Smit JJ van den Dungen JM Hooymans Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial Hum Gene Ther 17 2006 683 691
19. K Makinen H Manninen M Hedman P Matsi H Mussalo E Alhava Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study Mol Ther 6 2002 127 133
20. S Rajagopalan ER 3rd Mohler RJ Lederman FO Mendelsohn JF Saucedo CK Goldman Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication Circulation 108 2003 1933 1938